Hos patienter med kronisk obstruktiv lungesygdom (KOL) eller patienter med andre tilstande, der gør dem disponerede for hypoventilation, kan der forventes sværere bivirkninger.
In patients with chronic obstructive pulmonary disease or patients with conditions pre-disposing them to hypoventilation, more severe adverse reactions may be experienced.